Serial 79446771
Live / Applied — Non-final action mailed (as of 06 Jul 2026)
Now
Refused for now — an office action was mailed 07 Jul 2026.
A response is due by 07 Jan 2027; with no response the application is abandoned.
What this means for you
Not registered yet, but its 16 Jan 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79446771
- Mark type
- Design / logo
- Filed
- 16 Jan 2026
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for weight reduction and long term weight loss maintenance; pharmaceutical preparations for the treatment of cardiovascular diseases, chronic kidney disease, heart failure and hypertension.
Owner
- Novo Nordisk A/S, DK
Prosecution history
- 23 Jul 2026 — REFUSAL PROCESSED BY IB
- 07 Jul 2026 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 06 Jul 2026 — REFUSAL PROCESSED BY MPU
- 20 May 2026 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 19 May 2026 — NON-FINAL ACTION WRITTEN
- 14 May 2026 — ASSIGNED TO EXAMINER
- 30 Mar 2026 — APPLICATION FILING RECEIPT MAILED
- 30 Mar 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 26 Mar 2026 — SN ASSIGNED FOR SECT 66A APPL FROM IB